CNTB (Connect Biopharma Holdings) Marketable Securities : $0.00 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Connect Biopharma Holdings's Marketable Securities for the quarter that ended in Jun. 2024 was $0.00 Mil.

Connect Biopharma Holdings's annual Marketable Securities increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($73.41 Mil) but then declined from Dec. 2022 ($73.41 Mil) to Dec. 2023 ($12.65 Mil).

Connect Biopharma Holdings Marketable Securities Historical Data

The historical data trend for Connect Biopharma Holdings's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Marketable Securities Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

4.38

2.00

73.41

12.65

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Marketable Securities	Get a 7-Day Free Trial					49.34	73.41	49.76	12.65	-

Connect Biopharma Holdings Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Connect Biopharma Holdings (NAS:CNTB) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Connect Biopharma Holdings Marketable Securities Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.